Peter Maslak, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Maslak, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01266083 · WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)Sellas Life Sciences Group · completed · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT00528450 · Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic LeukemiaMemorial Sloan Kettering Cancer Center · terminated · Leukemia · principal investigator
- Ph2NCT00002567 · High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in RemissionMemorial Sloan Kettering Cancer Center · completed · Bone Marrow Ablation, Leukemia · study chair
- Ph2NCT00002800 · Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic SyndromeMemorial Sloan Kettering Cancer Center · completed · Leukemia, Myelodysplastic Syndromes, Neutropenia · study chair
- Ph2NCT00006019 · Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate CancerMemorial Sloan Kettering Cancer Center · completed · Leukemia, Lung Cancer, Lymphoma · study chair
- Ph1NCT00006040 · Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory LeukemiaMemorial Sloan Kettering Cancer Center · completed · Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA008748 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALEX MACDONALD · fiscal years 2011 to 2026Named on NCT00528450
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.